ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,831Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 151

$766K Total Retail Price of All Prescriptions

Rank: 24 out of 151

491 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 491 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,813 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 349 313 1 1
LEVOTHYROXINE SODIUM 306 255 2 2
NAMENDA 273 273 3 20
LISINOPRIL 236 203 4 5
DONEPEZIL HCL 215 207 5 15
BYSTOLIC 212 179 6 118
OMEPRAZOLE 207 179 7 4
FUROSEMIDE 199 175 8 6
WARFARIN SODIUM 178 159 9 9
AMLODIPINE BESYLATE 174 161 10 3
METOPROLOL TARTRATE 169 135 11 7
HYDROCODONE-ACETAMINOPHEN 161 99 S3 12 10
ZOLPIDEM TARTRATE 161 132 12 17
ESCITALOPRAM OXALATE 150 139 14 40
ATENOLOL 149 136 15 11
GABAPENTIN 131 91 16 14
METFORMIN HCL 129 83 17 8
LEVOFLOXACIN 121 87 18 80
DIOVAN 117 102 19 33
ATORVASTATIN CALCIUM 116 114 20 16
TRAZODONE HCL 111 93 21 48
HYDROCHLOROTHIAZIDE 106 101 22 13
OXYCODONE HCL 104 30 S2 23 67
TAMSULOSIN HCL 102 95 24 30
MIRTAZAPINE 99 82 25 28
AZITHROMYCIN 97 75 26 36
ALENDRONATE SODIUM 96 92 27 26
CYMBALTA 92 52 28 62
METOPROLOL SUCCINATE 86 81 29 21
CARVEDILOL 84 70 30 22
AMLODIPINE BESYLATE-BENAZEPRIL 82 74 31 89
JALYN 78 77 32 293
AMOX TR-POTASSIUM CLAVULANATE 76 61 33 115
CARISOPRODOL 75 0 R 34 141
GLIPIZIDE 74 54 35 43
PREDNISONE 73 59 36 45
FAMOTIDINE 72 72 37 64
NYSTATIN-TRIAMCINOLONE 68 61 38 165
SAVELLA 65 33 39 309
AMITIZA 65 39 39 309
IBUPROFEN 64 38 41 69
ISOSORBIDE MONONITRATE ER 63 62 42 55
SYNTHROID 62 56 43 60
TRIAMTERENE-HCTZ 61 36 44 68
TEMAZEPAM 61 61 44 49
CELEBREX 60 52 46 110
LEXAPRO 60 53 46 105
GLIMEPIRIDE 60 58 46 58
SINGULAIR 59 53 49 72
ADVAIR DISKUS 58 54 50 46
QUETIAPINE FUMARATE 57 40 51 53
POTASSIUM CHLORIDE 57 55 51 19
RISPERIDONE 56 42 53 50
CITALOPRAM HBR 55 50 54 18
MELOXICAM 53 43 55 57
VIIBRYD 53 40 55 336
DIGOXIN 53 53 55 39
LOVASTATIN 53 51 55 31
OXYCODONE HCL-ACETAMINOPHEN 52 28 S2 59 122
GEMFIBROZIL 50 29 60 104
CEPHALEXIN 50 29 60 108
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.